US Broker Ratings

Emergent BioSolutions Inc. (EBS) Investor Outlook: Analyzing the 6.89% Potential Upside Amidst Market Challenges

Emergent BioSolutions Inc. (NYSE: EBS), a pivotal player in the healthcare sector, stands out as a noteworthy consideration for investors keen on the drug manufacturing industry...

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: Strong Buy Ratings Highlight a Potential 53.97% Upside

Oruka Therapeutics, Inc. (NASDAQ: ORKA), a burgeoning player in the biotechnology sector, has recently captured the attention of investors with an impressive potential upside of 53.97%...

MeiraGTx Holdings plc (MGTX) Stock Analysis: Exploring a Potential 225% Upside in the Biotech Space

For investors with an appetite for biotechnology stocks, MeiraGTx Holdings plc (NASDAQ: MGTX) presents an intriguing opportunity. The company, based in New York, operates in the..

Atai Beckley N.V. (ATAI): Biotech Trailblazer with 195% Upside Potential

Atai Beckley N.V. (ATAI), a promising biotechnology company focused on revolutionizing mental health treatments, is gaining traction in the investment community for its remarkable growth potential...

Celcuity Inc. (CELC) Stock Analysis: Unveiling Growth Potential with a 7.69% Upside

Celcuity Inc. (NASDAQ: CELC), a promising player in the biotechnology sector, has attracted attention with its innovative approach to cancer treatment. With a market capitalization of..

Upstream Bio, Inc. (UPB) Stock Analysis: Unpacking a 57% Potential Upside in Biotechnology

Investors with an eye on the biotechnology sector may want to take a closer look at Upstream Bio, Inc. (NASDAQ: UPB). The clinical-stage biotech firm is..

Kamada Ltd. (KMDA) Stock Analysis: Potential Upside of 83% Amid Strong Buy Ratings

Kamada Ltd. (NASDAQ: KMDA), a key player in the healthcare sector, particularly in the drug manufacturing niche focusing on specialty and generic products, is capturing investor..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Exploring a 148% Potential Upside in the Biotech Sector

Oric Pharmaceuticals, Inc. (ORIC), a clinical-stage biopharmaceutical company, has captured the attention of investors with its innovative approach to cancer therapy and a promising potential upside..

Humacyte, Inc. (HUMA) Stock Analysis: A Biotech Innovator Poised for 627% Upside

Humacyte, Inc. (HUMA), a biotechnology company based in Durham, North Carolina, is capturing investor attention with its innovative approach to bioengineered human tissues. Specializing in the..

Akso Health Group (AHG) Stock Analysis: A 415.8% Revenue Surge Amidst Market Uncertainty

Akso Health Group, trading under the symbol AHG, is a noteworthy player in China’s healthcare sector, specifically within the medical distribution industry. Despite operating amidst a..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating a Challenging Landscape with a 25.9% Revenue Growth

Sonida Senior Living, Inc. (SNDA) stands as a key player in the healthcare sector, specifically within the medical care facilities industry in the United States. With..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Unlocking a 68.93% Potential Upside with Innovative CNS Treatments

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is rapidly emerging as a notable player within the biotechnology sector, specifically focusing on innovative solutions for central nervous system (CNS)..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Unpacking a Potential 115.98% Upside in a Challenging Market

In the competitive world of medical devices, Treace Medical Concepts, Inc. (NASDAQ: TMCI) stands out with its innovative offerings, particularly in the field of bunion correction...

Septerna, Inc. (SEPN) Stock Analysis: A Biotech Powerhouse with a 12,113% Revenue Growth Surge

Septerna, Inc. (SEPN), a clinical-stage biotechnology company, is capturing investor attention with its remarkable 12,113.10% revenue growth, positioning it as a noteworthy player in the healthcare..

Abivax SA (ABVX) Stock Analysis: A Biotech Powerhouse with Unwavering Buy Ratings

For investors with a keen eye on the biotechnology sector, Abivax SA (ABVX) presents a compelling case. With a market capitalization of $11.47 billion, this Paris-based..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Exploring a 38.57% Upside Potential in the Pediatric Orthopedic Market

OrthoPediatrics Corp. (NASDAQ: KIDS), a key player in the healthcare sector specializing in medical devices for pediatric orthopedic conditions, presents a compelling opportunity for investors with..

Bicycle Therapeutics plc (BCYC): Investor Outlook on a Biotechnology Pioneer with 207% Potential Upside

Bicycle Therapeutics plc (NASDAQ: BCYC), a clinical-stage biotechnology company based in Cambridge, UK, is capturing investor attention with its innovative approach to drug development and a..

Inventiva S.A. (IVA): Biotech Investor Outlook with a 245% Potential Upside

For those with an eye on the healthcare sector, particularly the burgeoning field of biotechnology, Inventiva S.A. (NASDAQ: IVA) presents an intriguing investment opportunity. With its..

InnovAge Holding Corp. (INNV) Investor Outlook: Navigating a Challenging Yet Promising Healthcare Landscape

InnovAge Holding Corp. (NASDAQ: INNV), a prominent player in the healthcare sector, specifically in the medical care facilities industry, presents an intriguing proposition for investors keen..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: A 44.8% Upside Potential Ignites Investor Interest

Organogenesis Holdings Inc. (NASDAQ: ORGO), a key player in the regenerative medicine industry, is gaining attention from investors with its impressive growth prospects. Specializing in advanced..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds